FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q28572175> ?p ?o ?g. }

• Q28572175 description "1999 թուականի Յունիսին հրատարակուած գիտական յօդուած" @default.
• Q28572175 description "1999 թվականի հունիսին հրատարակված գիտական հոդված" @default.
• Q28572175 description "article scientifique publié en 1999" @default.
• Q28572175 description "artículu científicu espublizáu en 1999" @default.
• Q28572175 description "im Juni 1999 veröffentlichter wissenschaftlicher Artikel" @default.
• Q28572175 description "scientific journal article" @default.
• Q28572175 description "vedecký článok (publikovaný 1999/06/11)" @default.
• Q28572175 description "vědecký článek publikovaný v roce 1999" @default.
• Q28572175 description "wetenschappelijk artikel (gepubliceerd op 1999/06/11)" @default.
• Q28572175 description "наукова стаття, опублікована в червні 1999" @default.
• Q28572175 description "مقالة علمية (نشرت في 11-6-1999)" @default.
• Q28572175 name "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase" @default.
• Q28572175 name "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase" @default.
• Q28572175 name "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase" @default.
• Q28572175 type Item @default.
• Q28572175 label "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase" @default.
• Q28572175 label "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase" @default.
• Q28572175 label "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase" @default.
• Q28572175 prefLabel "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase" @default.
• Q28572175 prefLabel "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase" @default.
• Q28572175 prefLabel "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase" @default.
• Q28572175 P1433 Q28572175-572157C3-AC3D-4F41-957D-4D3F00892A9A @default.
• Q28572175 P1476 Q28572175-A6C6E1B0-483B-4C22-BB1A-8F48F50435B0 @default.
• Q28572175 P2093 Q28572175-11E82B01-AB24-481C-B294-8CF1A9F3F5A8 @default.
• Q28572175 P2093 Q28572175-34153AF2-869D-4103-A20B-9AB377A85E48 @default.
• Q28572175 P2093 Q28572175-4002F801-4EC8-47F8-B940-D76B1AECF3EF @default.
• Q28572175 P2093 Q28572175-F7EEFE41-98F7-4268-ACB8-B49B73C1D757 @default.
• Q28572175 P2860 Q28572175-000B6F14-2FDB-4A1B-BDC2-298EC2CE70B2 @default.
• Q28572175 P2860 Q28572175-045CE514-3966-489C-A2A9-85C1404F9D6F @default.
• Q28572175 P2860 Q28572175-0C8CC9EC-9BD3-4958-94CC-F17847E9CFFD @default.
• Q28572175 P2860 Q28572175-1D1D563C-7F7A-4EA4-9426-D2FC17655FD1 @default.
• Q28572175 P2860 Q28572175-2A7BDFEE-D723-46CD-9078-317D70E723B2 @default.
• Q28572175 P2860 Q28572175-31C0B593-5193-445C-9DA2-406F474A2D64 @default.
• Q28572175 P2860 Q28572175-3B5BF871-3710-482D-ABB0-7CBDF331D458 @default.
• Q28572175 P2860 Q28572175-51B5CC05-5D9B-4FBB-B58B-142121E54D99 @default.
• Q28572175 P2860 Q28572175-5F104E78-AF43-4A6A-AAB8-8D1E914CBEDF @default.
• Q28572175 P2860 Q28572175-6E7A0375-2422-43DA-9D5E-B85A9930CEAC @default.
• Q28572175 P2860 Q28572175-70B23978-8D6C-499B-B5AE-8C252DC9D0D6 @default.
• Q28572175 P2860 Q28572175-7537E02C-3FC1-4393-843A-3DEF958716F6 @default.
• Q28572175 P2860 Q28572175-A10C2E26-DC9B-4076-8B79-BA6ABFA7DEBE @default.
• Q28572175 P2860 Q28572175-A77D2B0B-D2EE-474D-92D2-4AD3A36ED589 @default.
• Q28572175 P2860 Q28572175-B8CA344F-CAD6-4482-8D73-282A2A3826C9 @default.
• Q28572175 P2860 Q28572175-BE7B6193-B119-4518-BDBA-EDCB557E4DCE @default.
• Q28572175 P2860 Q28572175-C213A71B-977A-4279-B7DD-FEE4BE5A36EF @default.
• Q28572175 P2860 Q28572175-C477397C-29DB-421C-AC8A-BBAE6A0A7556 @default.
• Q28572175 P2860 Q28572175-CD699E4B-65DE-4DB4-904C-1562605D005F @default.
• Q28572175 P2860 Q28572175-DA4FC570-331C-4B94-A650-C3437FCFB94A @default.
• Q28572175 P2860 Q28572175-E76F70F9-3F8D-4EB7-A439-DABDBBC0AA9F @default.
• Q28572175 P2860 Q28572175-EBC596E4-99CD-412A-A65D-9FB296968191 @default.
• Q28572175 P2860 Q28572175-FA406985-1F72-4B2F-9D17-7E4C4B89426A @default.
• Q28572175 P304 Q28572175-CD370312-AFE4-44B6-8A33-406C529F07CE @default.
• Q28572175 P31 Q28572175-7DAE7DD2-2104-4E45-BD1B-3EC09FC08F29 @default.
• Q28572175 P3181 Q28572175-E31F7DD5-2EE1-447A-A4C1-D1ACC31505E5 @default.
• Q28572175 P356 Q28572175-795BDE2F-90A6-4E5F-B7B1-E7732AB866B3 @default.
• Q28572175 P407 Q28572175-F880F921-6662-4D3C-9EC4-5CD617862D4D @default.
• Q28572175 P433 Q28572175-879DDDAC-B224-481C-A66D-8063682ABED3 @default.
• Q28572175 P478 Q28572175-8C0E9D4D-1B5F-4473-B353-CC0DF2258D26 @default.
• Q28572175 P50 Q28572175-69BF9524-7F9D-4E1B-9510-836675360DEC @default.
• Q28572175 P50 Q28572175-B40C4573-C288-433A-901B-7A3A5F8514F2 @default.
• Q28572175 P577 Q28572175-7C64321A-606A-4C73-8F6B-513C44E13120 @default.
• Q28572175 P5875 Q28572175-B9950B90-EB9E-4EBE-9B11-3BA5A71A8814 @default.
• Q28572175 P698 Q28572175-BF2DB703-4BD8-4AA5-A945-D89EB3BE4ECD @default.
• Q28572175 P921 Q28572175-068731F0-A828-4C52-9D60-215C7D5BB53A @default.
• Q28572175 P921 Q28572175-7D35D44C-3E59-42B6-B7DC-129821764B49 @default.
• Q28572175 P3181 3229874 @default.
• Q28572175 P356 S0014-5793(99)00632-8 @default.
• Q28572175 P698 10386582 @default.
• Q28572175 P1433 Q1388051 @default.
• Q28572175 P1476 "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase" @default.
• Q28572175 P2093 "A. Tailleux" @default.
• Q28572175 P2093 "C. Fiévet" @default.
• Q28572175 P2093 "J. C. Fruchart" @default.
• Q28572175 P2093 "K. Schoonjans" @default.
• Q28572175 P2860 Q24300252 @default.
• Q28572175 P2860 Q24318461 @default.
• Q28572175 P2860 Q25938986 @default.
• Q28572175 P2860 Q28238069 @default.
• Q28572175 P2860 Q28264180 @default.
• Q28572175 P2860 Q28307151 @default.
• Q28572175 P2860 Q28646508 @default.
• Q28572175 P2860 Q28646525 @default.
• Q28572175 P2860 Q29391553 @default.
• Q28572175 P2860 Q33592002 @default.
• Q28572175 P2860 Q34467101 @default.
• Q28572175 P2860 Q34546130 @default.
• Q28572175 P2860 Q36694542 @default.
• Q28572175 P2860 Q37360326 @default.
• Q28572175 P2860 Q37728908 @default.
• Q28572175 P2860 Q39756744 @default.
• Q28572175 P2860 Q40505449 @default.
• Q28572175 P2860 Q42550850 @default.
• Q28572175 P2860 Q42813608 @default.
• Q28572175 P2860 Q42866998 @default.
• Q28572175 P2860 Q45093260 @default.
• Q28572175 P2860 Q51566349 @default.
• Q28572175 P2860 Q72583871 @default.
• Q28572175 P304 "160–164" @default.
• Q28572175 P31 Q13442814 @default.
• Q28572175 P3181 "3229874" @default.
• Q28572175 P356 "10.1016/S0014-5793(99)00632-8" @default.

• next